GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Sale Of Business

Abattis Bioceuticals (Abattis Bioceuticals) Sale Of Business : $0.00 Mil (TTM As of Sep. 2019)


View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Sale Of Business?

Abattis Bioceuticals's sale of business for the three months ended in Sep. 2019 was $0.00 Mil. It means Abattis Bioceuticals gained $0.00 Mil from selling business. Abattis Bioceuticals's sale of business for the trailing twelve months (TTM) ended in Sep. 2019 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Jun. 2019 ), Abattis Bioceuticals gained the same money from selling business in Sep. 2019 ($0.00 Mil).


Abattis Bioceuticals Sale Of Business Historical Data

The historical data trend for Abattis Bioceuticals's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Sale Of Business Chart

Abattis Bioceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.53 -

Abattis Bioceuticals Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Abattis Bioceuticals Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abattis Bioceuticals Sale Of Business Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Traded in Other Exchanges
N/A
Address
1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6
Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.

Abattis Bioceuticals (Abattis Bioceuticals) Headlines

From GuruFocus

Abattis Announces Share Buy Back Program

By Marketwired Marketwired 08-07-2018

Abattis Strengthens Management Team and Provides Company Updates

By Marketwired Marketwired 09-11-2018

Abattis Provides Marketing and Operational Updates

By Marketwired Marketwired 12-21-2018

Abattis Bioceuticals Announces Release of New Line of Vaporizers

By Marketwired Marketwired 05-22-2018

Abattis Comments on BCSC Temporary Order

By Marketwired Marketwired 11-28-2018

Comfort Launch by Vergence Naturals Exceeds Expectations

By Marketwired Marketwired 12-11-2018